Penn Heart and Vascular

Hybrid Revascularization at the Coronary Artery Disease Program

Quality & Outcomes: Hybrid Revascularization

Hybrid Revascularizations in Penn's Hybrid OR/Cath Labs

Originating in a partnership between cardiovascular surgeons and interventional cardiologists the hybrid OR/cath labs introduced a new way of treating cardiovascular disease based on the concept of performing endovascular aortic and transcatheter aortic valve interventions sequentially in the same space.

An increasing number of hybrid coronary revascularization procedures are being performed in the hybrid OR/cath labs at Penn. These procedures combine off-pump minimally invasive CABG with concomitant percutaneous coronary interventions (PCIs) to achieve complete revascularization for high-risk patients with coronary artery disease. Advantages include minimally invasive incisions, shorter ICU and hospital stays and an earlier return to satisfactory quality of life.

Other surgeries performed in the hybrid OR/cath labs at Penn include concomitant minimally invasive valve repair/replacement, coronary surgery, and complex hybrid thoracic aortic surgery combining conventional open aortic repair with endovascular stent graft therapy.

Penn Heart & Vascular Clinical Activity Reports

See Interactive Report or Download PDF Version